The only thing that needs fixing is your attitide. Everything that Mark announced in Dec 14 has happened (except for the 1102 partnership). Sure we would like more detail on the 1103 deal, but non disclosure is common with Bio licensing, so no surprises there. All we need is the 1102 partnership and we are 100% on target.
- Forums
- ASX - By Stock
- PER
- Ann: ATL1102 Early Access Program for Patients with MS
Ann: ATL1102 Early Access Program for Patients with MS, page-21
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $94.66M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 9.8¢ | $49.85K | 497.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 101000 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 282099 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 101000 | 0.098 |
1 | 30927 | 0.097 |
2 | 20342 | 0.096 |
1 | 100000 | 0.095 |
3 | 40000 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 282099 | 4 |
0.110 | 353014 | 3 |
0.115 | 583850 | 5 |
0.120 | 381142 | 9 |
0.125 | 110429 | 2 |
Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |